Document Detail


The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
MedLine Citation:
PMID:  8406189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
With the development of new intraperitoneal treatments in ovarian cancer, safe and convenient access to the peritoneal cavity is now required. This report reviews the University of Alabama at Birmingham's experience with the Groshong catheter as an intraperitoneal access device. The Groshong was easily inserted intraperitoneally in 20 ovarian cancer patients and used to deliver 81 courses of intraperitoneal therapy over 2310 patient-days. There were no catheter-related complications during treatment and only one exit site infection after catheter removal. Further investigation of the Groshong catheter as a novel intraperitoneal access device appears warranted.
Authors:
R W Naumann; R D Alvarez; E E Partridge; L C Kilgore; J M Austin
Related Documents :
8001879 - Preoperative ultrasound assessment of omental spread in ovarian cancer.
14998939 - Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cr...
7338869 - Familial ovarian cancer. how rare is it?
15160929 - Secondary acute monocytic leukemia with a translocation t(8;16)(p11;p13): case report a...
16006439 - Regulation of primordial follicle assembly and development.
19308749 - Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderlin...
17530019 - Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal anti...
15183799 - Clinical and immunologic aspects of cancer-associated retinopathy.
14612919 - Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hyp...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Gynecologic oncology     Volume:  50     ISSN:  0090-8258     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  1993 Sep 
Date Detail:
Created Date:  1993-11-01     Completed Date:  1993-11-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  291-3     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Alabama at Birmingham 35233-7333.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / administration & dosage*,  therapeutic use
Catheterization / methods*
Catheters, Indwelling*
Female
Humans
Infusions, Parenteral / instrumentation
Laparoscopy
Ovarian Neoplasms / drug therapy*,  surgery
Peritoneum
Reoperation
Retrospective Studies
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative ...
Next Document:  Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of c...